Aurisco Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -3.16% vs 19.79% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -46.48% vs 45.26% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "389.30",
          "val2": "402.00",
          "chgp": "-3.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.50",
          "val2": "163.30",
          "chgp": "-45.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "8.20",
          "chgp": "12.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.60",
          "val2": "1.60",
          "chgp": "62.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "63.90",
          "val2": "119.40",
          "chgp": "-46.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "227.30%",
          "val2": "340.20%",
          "chgp": "-11.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.81% vs 16.93% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 26.61% vs 22.73% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,689.10",
          "val2": "1,471.20",
          "chgp": "14.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "657.50",
          "val2": "474.20",
          "chgp": "38.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "35.60",
          "val2": "16.80",
          "chgp": "111.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.40",
          "val2": "2.30",
          "chgp": "91.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "449.20",
          "val2": "354.80",
          "chgp": "26.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "313.30%",
          "val2": "261.00%",
          "chgp": "5.23%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

389.30

402.00

-3.16%

Operating Profit (PBDIT) excl Other Income

88.50

163.30

-45.81%

Interest

9.20

8.20

12.20%

Exceptional Items

2.60

1.60

62.50%

Consolidate Net Profit

63.90

119.40

-46.48%

Operating Profit Margin (Excl OI)

227.30%

340.20%

-11.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -3.16% vs 19.79% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -46.48% vs 45.26% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,689.10

1,471.20

14.81%

Operating Profit (PBDIT) excl Other Income

657.50

474.20

38.65%

Interest

35.60

16.80

111.90%

Exceptional Items

4.40

2.30

91.30%

Consolidate Net Profit

449.20

354.80

26.61%

Operating Profit Margin (Excl OI)

313.30%

261.00%

5.23%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 14.81% vs 16.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 26.61% vs 22.73% in Dec 2024

All Annual Results